Like many pharmaceutical drugs, Lipitor can cause problems as serious as those it is solving. Lipitor is prescribed to lower ‘bad’ (LDL) cholesterol and triglycerides as well as to raise ‘good’ (HDL) cholesterol. It is also supposed to lowerthe risk of heart attack, stroke, and chest pain. But, Lipitor lawsuits have risen as a result of the drug’s link to type 2 diabetes, which has been validated by numerous studies.
The drug was approved by the Food and Drug Administration (FDA) in 1996 and is distributed by Pfizer, an American pharmaceutical company. It is also known by its generic name atorvastatin.
Lipitor is a statin, a class of drugs used to lower lipids and prevent the liver from producing cholesterol. But, statins are also linked to elevated blood sugar levels. Lipitor side effects can range from irritating to life-threatening and they are not always made clear to those using the drug.
Some of the more severe yet lesser known side effects of Lipitor include:
- Memory loss
- Muscle problems
- Liver problems
- Kidney failure
- Type 2 diabetes
These Lipitor adverse reactions can be alarming as well dangerous. Seek a doctor immediately if you are experiencing any of these symptoms.
If you believe that you or a loved one has been negatively affected by Lipitor, contact the Lipitor lawyers at Simmons Hanly Conroy.… Read the rest
Earlier this year, Boehringer Ingelheim, the manufacturer of Pradaxa (dabigatran), agreed to pay $650 million in a comprehensive settlement related to lawsuits issued by users of the drug. Reports of death, bleeding and stroke among individuals taking the blood-thinning medication have been ongoing since its introduction to the market in October, 2010.
Numerous studies have focused on the link between Pradaxa and serious side effects. In December 2011, U.S. regulators issued a safety announcement regarding the post-market reports of serious bleeding events among Pradaxa users. More than 260 fatal bleeding incidents have been confirmed by Boehringer Ingelheim.
The comprehensive settlement decision comes from the knowledge that the blood thinner manufacturer may have failed in its duty to adequately warn consumers about the frequency of bleeding events compared to traditional anticoagulants. Warfin, the long-standing blood-thinning medication has a reversal agent or antidote for dangerous side effects, while Pradaxa does not.
The settlement agreement comes less than a year after Boehringer Ingelheim filed for additional marketing approvals for Pradaxa, according to the NY Tmes. The additional marketing would present the drug as a treatment for deep vein thrombosis and pulmonary embolism.
Simmons Hanly Conly Pradaxa lawyers are no longer accepting clients in this area.… Read the rest
An advisory panel to the U.S. Food and Drug Administration (FDA) recently voted 20-1 that further assessment of the health risks of testosterone therapy is needed among drugmakers. Among the panel, 16 voted that testosterone should only be studied in some situations, Bloomberg reported.
The panel also agreed that the FDA should revise who should be prescribed testosterone medications. This backs up the claim that there is little evidence supporting the effectiveness of testosterone replacement therapies for treating low T due to aging.
Use of testosterone began in the 1950s among men who had medical conditions leading to testosterone deficiencies, such as testicular damage from chemotherapy. In recent years, however, use has grown substantially among men with no other reason for low testosterone other than natural aging.
“About 20 percent of patients on the treatments don’t have laboratory evidence showing they need them,” the Bloomberg article states.
Previous studies have linked testosterone replacement therapies to an increased risk of heart attack, stroke or death. The study, published in PLOS ONE, an international, peer-reviewed online publication in January, 2014, is a part of the growing body of research on testosterone heart risk that raises concerns about the increased risk associated with taking testosterone therapy.… Read the rest
Risperdal is currently used to treat severe psychiatric disorders despite escalating reports of unhealthy weight gain and gynecomastia. Due to the drug’s success and its lack of proper warning, though, doctors continue to use it to treat schizophrenia, schizoaffective disorder, bipolar disorder and autism.
Risperdal is categorized in the class of atypical antipsychotic drugs, which is one of the most popular classes of prescription drugs. Atypical antipsychotics, while curbing psychotic symptoms, dramatically increase the appetites of those dependent on them. Studies show up to 30 percent of patients taking them experience weight gain of at least 7 percent of their body weight.
But, even when those with increased appetites eat well and exercise, they continue to gain weight. This indicates that hormones play a role in weight gain, tying it to other side effects of the drug. Even lesser known than the Risperdal side effect of weight gain, though, is its connection with gynecomastia.
Risperdal and Gynecomastia
Risperdal and gynecomastia are linked, causing some young males who take the medication to develop breasts, which can secrete milk. Gynecomastia side effects, on the other hand, include:
- Lowered self-esteem
- Decreased social functioning
- Diminished mental & physical health
- Lessened standard quality of life
Gynecomastia can easily be confused with weight gain, though, as many people are not aware of the condition.… Read the rest
Gynecomastia is a condition that has been linked to the use of Risperdal among adolescent boys. It involves the enlargement of male breasts as well as the secretion of milk. Male breasts are caused by an increased level of the hormone prolactin, which regulates the growth of breast tissue.
While there are multiple causes of gynecomastia, one of the most recent causes is the use of Risperdal, which is a prescription medication used to treat schizophrenia, autism and bipolar disorders. The drug was approved for children and adolescents experiencing irritability from autism in 2006.
Many people are unaware of the connection between Risperdal and gynecomastia, as well as the condition itself. Below, we’ve outlined some of the most important gynecomastia facts to know according to the John Hopkins Medicine. These are especially important for those currently taking Risperdal.
- Including all known causes of gynecomastia, the condition most often occurs during puberty.
- The condition often begins as a small lump under the nipple in one or both of the breasts, which may feel tender.
- Other symptoms of gynecomastia may be similar to other medical conditions, so it’s important to talk to your doctor if you notice anything out of the ordinary.
… Read the rest